Zoundream

What Zoundream does

Zoundream AG is a Basel-based artificial intelligence company founded in 2019 that develops proprietary deep-learning technology for interpreting and translating infant cries. Its core technology, AMSI (Acoustic Multi-Stage Interpreter), processes continuous audio through a series of inner deep-learning models to extract meaning, classifying cries into actionable categories (hungry, sleepy, fussy, gassy, agitated, need to burp, distress) with reported 92% accuracy, and identifying potential neurodevelopmental conditions such as autism spectrum disorder and infantile colic with 90-94% accuracy across published clinical studies. The platform is built on what the company describes as the world's largest proprietary infant cry dataset, with over 100,000 hours of testing data collected in home environments, and has been extended into multimodal analysis combining acoustic signals with EEG, NIRS, facial expressions, and body language.

The company operates a B2B OEM-embedded business model, licensing its cry analysis technology (branded BeyondCry for Motorola Nursery products and CryAssist for Maxi-Cosi products) to leading global baby product manufacturers including Dorel Juvenile (Maxi-Cosi, Safety 1st, Tiny Love, Cosco), Philips Avent, and Motorola Nursery (developed with SGW Global). These integrations are distributed through major retail channels including Amazon and global baby product retailers. A secondary revenue stream comes from clinical research services, supported by the multi-center NeoDream study with leading European and Latin American hospitals (Hospital Sant Joan de Déu Barcelona, Vall d'Hebron, La Paz, UMC Utrecht, Hospital Clínic Barcelona, Fundación Salud Infantil, Kolob Autism Center Peru). The company has also integrated Babbly's speech development monitoring technology (acquired July 2024), expanding its scope from cry analysis into broader infant developmental tracking.

Zoundream maintains operations across Switzerland (Basel HQ), Spain (Barcelona operating subsidiary Zoundream S.L.), and a contact presence in New York, with active markets in EMEA, North America, and Latin America. It holds ISO 27001:2022 (information security), ISO/IEC 42001:2023 (AI management system), GDPR, and HIPAA compliance certifications. The company has raised approximately EUR 4 million in seed funding (September 2025) led by CRB Health Tech, alongside earlier rounds and a 2026 CDTI INNVIERTE investment, and has been recognized through multiple industry awards including Hello Tomorrow Deep Tech Pioneer 2024 and 4YFN/MWC Top Digital Health Startup.

Name

Zoundream

Legal name

Zoundream, S.L.

Website

https://zoundream.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Zoundream is a Basel-based AI company that uses proprietary AMSI deep-learning technology to analyze infant cries, translating them into actionable needs and detecting neurodevelopmental conditions. It licenses the technology to OEMs including Maxi-Cosi, Philips Avent, and Motorola Nursery, and runs the NeoDream clinical study with major hospitals.

Ownership category

akta.pro rank

Product category

AI Audio Analytics

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG)

akta.pro secondary industries

Maternal & Neonatal Remote Monitoring Platforms (HLACAFAC), Speech & Language Therapy (Early Intervention) (EDACAFAB), Social-Emotional Learning (SEL) & Behavior Support Apps (EDACANAD)

Keywords

• Infant cry analysis
• AI sound recognition
• Neonatal health AI
• OEM licensing AI
• Vocal biomarker screening

Headquarters

HQ city

Basel

HQ country

Switzerland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Technology Licensing to OEM Partners: Zoundream licenses its AMSI cry analysis technology to baby product manufacturers like Dorel Juvenile (Maxi-Cosi, Safety 1st), Philips Avent, and Motorola Nursery (SGW Global). Revenue is generated through licensing fees, technology integration fees, and potentially per-unit royalties embedded in consumer hardware products.
2. Clinical Research Services: Revenue from conducting clinical studies with hospitals and healthcare institutions to validate cry analysis technology for medical applications including autism screening and pathology detection.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Zoundream develops and licenses proprietary deep-learning AI technology (AMSI - Acoustic Multi-Stage Interpreter) that analyzes and translates infant cry sounds into actionable categories such as hungry, sleepy, fussy, gassy, agitated, and distress. The technology is licensed to baby product manufacturers (Motorola Nursery, Philips Avent, Maxi-Cosi/Dorel Juvenile) for integration into smart baby monitors and bassinets, and is also validated through clinical research partnerships with hospitals for early screening of neurodevelopmental disorders such as autism.

Product overview

Zoundream offers an AI-based infant cry analysis ecosystem centered on its proprietary AMSI (Acoustic Multi-Stage Interpreter) deep-learning technology. The core AMSI platform processes infant cry audio to classify needs (hungry, sleepy, fussy, gassy, agitated, distress) and detect potential neurodevelopmental conditions. This technology is deployed through two branded modules—BeyondCry (in Motorola Nursery monitors) and CryAssist (in Maxi-Cosi See Pro and Starling Smart Bassinet)—integrated into consumer baby monitors and bassinets sold by strategic partners. The company also acquired Babbly's speech development monitoring technology to expand into developmental tracking. A multicentric clinical study called NeoDream is validating the technology for early screening of autism and other pathologies.

Differentiator

Problem solved

Functional benefit

Brands

• AMSI (Acoustic MultiStage Interpreter): Deep-learning-based AI solution that interprets and translates baby cries into their actual meaning.
• BeyondCry
• CryAssist

Products and services

• AMSI (Acoustic Multi-Stage Interpreter) Proprietary deep-learning-based audio processing engine that interprets and translates baby cries into meaningful categories (hungry, sleepy, fussy, gassy, agitated, distressed). Uses multi-stage inner deep-learning models to extract acoustic features and classify cry types with 92-96% accuracy. Licensed to OEMs for integration into baby monitors, bassinets, and clinical applications.
• BeyondCry Cry detection, translation and insights technology branded under BeyondCry, licensed for integration into Motorola Nursery baby monitors (e.g., PIP1710 CONNECT). Provides real-time analysis of baby cries to identify needs such as hunger, sleepiness, discomfort, and distress.
• CryAssist AI cry translation technology branded under CryAssist, licensed for integration into Maxi-Cosi See Pro baby monitor and Starling Smart Bassinet. Translates baby cries into categories including sleepy, hungry, fussy, gassy, or agitated.
• Babbly Speech Development Monitoring Pioneering speech development monitoring technology acquired from Babbly in July 2024. Combined with cry analysis on Zoundream's platform to offer comprehensive infant developmental assessment including vocalization tracking.
• NeoDream Clinical Study Multicentric international clinical study assessing AI-powered cry analysis as vocal biomarker to support clinicians in early screening of pathologies and neurodevelopmental conditions including autism during first months of life. Partners include Hospital Sant Joan de Déu Barcelona, Vall d'Hebron University Hospital, La Paz University Hospital, UMC Utrecht, and Kolob Autism Center Peru.

Quantifiable outcome

• 92% accuracy in cry detection and translation
• +6 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature7 records

Scale indicators8 records

Recent moves8 records

Expansion highlights7 records

Broad incumbents

• VTech: Large consumer electronics manufacturer with a significant baby monitor product line. A broad incumbent whose scale in baby monitors could enable rapid in-house cry AI capability, making it a relevant competitor and potential acquirer of Zoundream.
• Summer Infant: Established baby products and monitor company. Broad incumbent in the same retail channels Zoundream's OEM partners sell into; comparable through its baby monitor portfolio and consumer distribution.

Direct peers

• Nanit: AI-powered smart baby monitor company offering computer-vision-based sleep tracking and infant insights. Directly comparable to Zoundream as both sell AI-driven infant monitoring intelligence through consumer hardware channels to the same parent segment.
• Owlet: Smart baby monitoring company known for the Owlet Smart Sock and broader connected nursery platform. Comparable to Zoundream through its consumer hardware+AI subscription model targeting infant health and parental peace of mind.
• Cubo AI: AI baby monitor with cry detection, face covering alerts, and sleep analytics. Directly overlaps with Zoundream's cry analysis and baby monitor OEM go-to-market, serving the same premium parent segment.
• Miku: Smart baby monitor that uses sensor fusion to track breathing, sleep, and nursery conditions. Comparable to Zoundream through its premium AI baby monitor offering and focus on parental reassurance.
• Hatch (formerly Hatch Baby): Connected nursery products including Restore sound machines and Grow smart changing pads. Overlaps with Zoundream on the connected nursery/parent category and consumer distribution through Amazon and baby retailers.
• Lullaai: AI-powered baby cry translation app. Closest direct competitor to Zoundream's cry-to-meaning translation use case, serving parents through a direct-to-consumer mobile offering rather than OEM licensing.

Emerging players

• Pampers Lumi: P&G's connected baby system combining Lumi diapers with an activity sensor and app. Adjacent competitor with massive distribution potential that could quickly enter cry analytics through partnership or in-house development.
• Empatica: Medical-grade wearable and AI biomarker company with FDA-cleared epilepsy detection. Comparable to Zoundream through its focus on AI-driven health biomarkers from physiological signals, including a regulatory pathway Zoundream may eventually pursue.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/zoundream

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds8 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zoundream